Siga Technologies (SIGA) Short term Debt (2012 - 2019)
Siga Technologies' (SIGA) quarterly Short term Debt came in at $80.0 million in Q4 2019, down 14.85% quarter-over-quarter from $94.0 million in Q3 2016.
Analysis
Siga Technologies (SIGA) Short term Debt (2012 - 2019) Analysis & Trends
Siga Technologies (SIGA) has reported Short term Debt for 5 consecutive years, with $80.0 million the latest figure, recorded in Q4 2019.
- For the quarter ending Q4 2019, Short term Debt changed N/A year-over-year to $80.0 million; the trailing twelve-month figure through Dec 2019 stood at $80.0 million (changed N/A YoY), and the FY2019 full-year result was $80.0 million, changed N/A from the prior year.
- Short term Debt fell to $80.0 million in Q4 2019 per SIGA's latest filing, from $94.0 million in the prior quarter.
- Across five years, Short term Debt topped out at $203.7 million in Q2 2016 and bottomed at $80.0 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 80.04 Mn |
| Sep 30, 2016 | 94.00 Mn |
| Jun 30, 2016 | 203.65 Mn |
| Dec 31, 2014 | 1.99 Mn |
| Sep 30, 2014 | 1.98 Mn |
| Jun 30, 2014 | 1.98 Mn |
| Mar 31, 2014 | 1.97 Mn |
| Dec 31, 2013 | 1.97 Mn |
| Sep 30, 2013 | 1.96 Mn |
| Jun 30, 2013 | 8.96 Mn |
| Mar 31, 2013 | 1.45 Mn |
| Dec 31, 2012 | 954,738.00 |